Moreover, FABP7 is co-expressed with Sox2 in gliomas and FABP7+/Sox2+ cells are found more abundantly in GBMs compared to lower grade astrocytomas, indicating FABP7 as a potential GSC biomarker [119]. This evidence concerns the gene SOX2 and glioma.